CVE-2026-5781
Multiple vulnerabilities in MphRx's Minerva
Vexday Risk Score
21Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 8.5EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —
Lifecycle
28 Apr 2026Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:H/SA:H
Affected products
MphRx · Minerva